Outline
| Key Fields |
Project for Seeds Development and Research Base
|
| R&D Phase |
Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study
|
| Contact |
-
Division of Research Programs, Department of International Strategy
- TEL: +81-3-6870-2216
- E-mail: sicorp”at”amed.go.jp(Replace “at” with @)
|
The aim of this program is to contribute solutions to challenges facing world today and to bolster Japan’s scientific and technological capabilities through collaboration with a broad range of countries．
This program provides support for international joint research projects on the basis of equal partnership in countries，regions，and fields of cooperation that have been designated as particularly important by the Ministry of Education，Culture，Sports，Science and Technology(MEXT)on the basis of intergovernmental agreements，in collaboration with funding agencies in the countries concerned．
Implementing Body
SICORP(UK)
- Research Area – "Infectious Diseases"
- The overarching aim of the UK-Japan collaborative initiative in infectious diseases is to provide bi-lateral support to biomedical and health researchers in the UK and Japan that will allow them to forge lasting collaborations. This initative aims to strengthen existing links or foster new links that add value to research taking place in both countries. This is expected to be achieved by facilitating exchange and catalysing innovative synergy amongst collaborators and is particularly aimed at those who are in the early stages of their careers.
- Funding Agency of the UK Side
- The UK Medical Research Council(MRC)
- Duration: FY2019 - FY2022
| Project Title |
Systematic analysis of persistence mechanisms by high-throughput bar-seq and single cell analyses |
| Country |
Japan |
U.K. |
| PI |
Dr.MUTO-FUJITA Ai |
Dr.Suzie Hingley-Wilson |
| Affiliation |
RIKEN |
University of Surrey |
SICORP(Germany)
- Research Area – "Neuroscience - Computational Connectomics"
- The aim of the collaborative project is to provide bi-lateral support to biomedical and health researchers in Japan and Germany that will allow them to forge lasting collaborations in the field of neuroscience-computational connectomics.
- Funding Agency of German Side
- Deutsche Forschungsgemeinschaft e.V (DFG)
- Duration: FY2020-FY2023
| Project Title |
The role of dynamic neural functional coupling in spontaneous thought |
| Country |
Japan |
Germany |
| PI |
Dr.Mingbo Cai |
Dr.Nicolas Schuck |
| Affiliation |
The University of Tokyo |
Max Planck Institute for Human Development |
SICORP(Canada)
- Research Area – "Advancing Epigenetic Technologies"
- The aim is to support Japan- and Canada-based early career researchers develop fruitful international collaborations in the field of epigenetic mechanisms and technologies.
- Funding Agency of Canadian Side
- Canadian Institutes of Health Research (CIHR)
- Duration: FY2020-FY2023
| Project Title |
Artificial Intelligence based adaptive and interpretable models for analyzing multi-track epigenomic sequential data |
| Country |
Japan |
Canada |
| PI |
Dr. YAMANAKA Soichiro |
Dr. Ahmed Ashraf |
| Affiliation |
The University of Tokyo |
University of Manitoba |
| Project Title |
Single-cell probing of epigenetic memory in immunity |
| Country |
Japan |
Canada |
| PI |
Dr.Jay Shin |
Dr.David Langlais |
| Affiliation |
RIKEN |
McGill University |
| Project Title |
Characterization of the integrative epigenetic and epitranscriptomic
landscape of acute myeloid leukemias |
| Country |
Japan |
Canada |
| PI |
Dr.YOSHIMI Akihide |
Dr.Ly Vu |
| Affiliation |
National Cancer Center Research Institute |
Simon Fraser University |
SICORP(Lithuania)
- Research Area – "Basic research with the use of clinical data and bioresources in rare and undiagnosed diseases, and cancer"
- The aim of the collaborative project is to provide bi-lateral support to biomedical and health researchers in Japan and the Republic of Lithuania that will allow them to forge lasting collaborations in the field of basic research with the use of clinical data and bioresources in rare and undiagnosed diseases, and cancer.
- Funding Agency of Lithuanian Side
- Ministry of Health of the Republic of Lithuania
- Duration: FY2021-FY2024
| Project Title |
The interaction of nutrition, metagenomic and molecular gastric microenvironment factors in Helicobacter pylori-induced gastric carcinogenesis |
| Country |
Japan |
Lithuania |
| PI |
Dr.SUZUKI Hidekazu |
Dr.Juozas Kupcinskas |
| Affiliation |
Tokai University School of Medicine |
Lithuanian University of Health Sciences |
| Project Title |
Radiogenomic patterns of BRCA1 / 2 breast cancer |
| Country |
Japan |
Lithuania |
| PI |
Dr. NAKAMURA Seigo |
Dr. Jurgita Ušinskienė |
| Affiliation |
Showa University School of Medicine |
National Cancer Institute |
SICORP (Nordic countries)
- Research Area – "Healthy Longevity"
- The aim of the collaborative project is to generate new knowledge on healthy ageing and longevity through Japanese-Nordic research collaboration by utilisation of existing high-quality health data sources in a Japanese-Nordic context.
- Funding Agency on the Nordic Side
- Academy of Finland, Research Council of Norway, Swedish Research Council, and NordForsk
- Duration: FY2021-FY2024
| Project Title |
Nordic-Japan multidomain interventions for healthy aging and prevention of dementia and disability |
| Role |
Project Leader |
Japan-based co-PI |
| Country |
Sweden |
Japan |
| PI |
Dr.Miia Kivipelto |
Dr.ARAI Hidenori |
| Affiliation |
Karolinska Institute |
National Center for Geriatrics and Gerontology |
| Project Title |
Molecular and structural biomarkers for personalised care in osteoarthritis |
| Role |
Project Leader |
Japan-based co-PI |
| Country |
Sweden |
Japan |
| PI |
Dr.Martin Englund |
Dr.ISHIJIMA Muneaki |
| Affiliation |
Lund University |
Juntendo University |
| Project Title |
Unveiling the risk factors of ageing to promote healthy longevity |
| Role |
Project Leader |
Japan-based co-PI |
| Country |
Norway |
Japan |
| PI |
Dr.Evandro Fei Fang |
Dr.YOKOTE Koutaro |
| Affiliation |
University of Oslo |
Chiba University |
SICORP(UK)
- Research Area – "Neuroscience, Neurodegenerative Disease and Dementia"
- The aim of the collaborative project is to address major questions in the fields of neuroscience, neurodegenerative disease and dementia, leveraging strengths of researchers in both the UK and Japan. It is expected that project outcomes will lead to next generation neuroscience research.
- Funding Agency of the UK Side
- The UK Medical Research Council(MRC)
- Duration: FY2022-FY2025
| Project Title |
Synaptic Pathology in ALS-FTD |
| Country |
Japan |
U.K. |
| PI |
Dr. OKABE Shigeo |
Dr. Seth Grant |
| Affiliation |
The University of Tokyo |
University of Edinburgh |
| Project Title |
Multi-analyte prognostic and diagnostic screening in blood and skin for Alzheimerʼs disease |
| Country |
Japan |
U.K. |
| PI |
Dr.TSUKAKOSHI Kaori |
Dr.Sanjiv Sharma |
| Affiliation |
Tokyo University of Agriculture and Technology |
Swansea University |
| Project Title |
Deciphering synaptic dysfunctions of human cognitive disease gene mutations via optical physiological and neurochemical strategies |
| Country |
Japan |
U.K. |
| PI |
Dr.BITO Haruhiko |
Dr.Nigel Emptage |
| Affiliation |
The University of Tokyo |
University of Oxford |
SICORP(Australia)
- Research Area – "Research and development on the prevention, diagnosis and/or treatment of dementia"
- The aim of the collaborative project is to deliver research funding for internationally competitive and innovative collaborations between early career researchers and established researchers from Australia and Japan in the field of dementia research.
- Funding Agency of Australia Side
- The National Health and Medical Research Council (NHMRC)
- Duration: FY2023-FY2025
| Project Title |
Reducing Cognitive impairment by management of Heart Failure as a Modifiable Risk Factor: the Cog-HF trial |
| Country |
Japan |
Australia |
| PI |
Dr.OBOKATA Masaru |
Dr.Quan Huynh |
| Affiliation |
Gunma University |
Baker Heart and Diabetes Institute |
| Project Title |
Exploring biomarkers, therapeutic targets, and modifiable risk factors for non-Alzheimer's dementia |
| Country |
Japan |
Australia |
| PI |
Dr.KAGAWA Yoshiteru |
Dr.Yijun Pan |
| Affiliation |
Tohoku University |
The University of Melbourne
Florey Institute of Neuroscience and Mental Health |
| Project Title |
Novel therapeutic strategies to intervene in tau-associated neurodegeneration by modulating tau clearance and neuroinflammation |
| Country |
Japan |
Australia |
| PI |
Dr.YAMADA Kaoru |
Dr.Chien-Hsiung Yu |
| Affiliation |
The University of Tokyo |
The University of Melbourne
Florey Institute of Neuroscience and Mental Health |
SICORP(Singapore)
- Research Area– “Cancer Complexity”
- The aim of the collaborative project is to strengthen collaborations between Japan and Singapore in the biomedical field and promote research and development, leveraging strengths of researchers in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration:FY2023-FY2026
| Project Title |
Decoding the molecular and cellular complexities for therapy response and transformation in myeloid leukemia |
| Country |
Japan |
Singapore |
| PI |
Dr.ITO Takahiro |
Dr.S.Tiong Ong |
| Affiliation |
Kyoto University |
Duke-NUS Medical School |
| Project Title |
Epigenomic Impacts by Asian-prevalent Carcinogens in the Evolution and Complexity of Asian Cancers |
| Country |
Japan |
Singapore |
| PI |
Dr.KANEDA Atsushi |
Dr.Bin Tean Teh |
| Affiliation |
Chiba University |
National Cancer Centre Singapore |
| Project Title |
Elucidating the roles of intra- and extracellular effectors of cancer as modulators of the immune system |
| Country |
Japan |
Singapore |
| PI |
Dr.KONDO Yutaka |
Dr.Shyam Prabhakar |
| Affiliation |
Nagoya University |
A*STAR Genome Institute of Singapore |
Results Report
Management and Evaluation Framework
PS(Program Supervisor)
SUDA Toshio, M.D., Ph.D., Director and Professor, International Research Center for Medical Sciences, Kumamoto University
PO(Program Officer)
SICORP(UK)
Research Area - "Neuroscience, Neurodegenerative disease and Dementia"
IWATSUBO Takeshi, M.D., Ph.D., Professor, Department of Neuropathology, Graduate School of Medicine, The University of Tokyo
SICORP(Lithuania)
ENDO Hiroyoshi, M.D., M.P.H., Ph.D., Professor Emeritus, St. Luke’s International University
SICORP(Nordic countries)
NAKAGAWA Hidewaki, M.D., Ph.D., Team Leader, Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences
SICORP(Australia)
IWATSUBO Takeshi, M.D., Ph.D., Professor, Department of Neuropathology, Graduate School of Medicine, The University of Tokyo
SICORP(Singapore)
USHIJIMA Toshikazu, M.D., Ph.D., President, Hoshi University
